The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
70
Bright light therapy will be provided via the Verilux HappyLight. The unit will be placed on a mobile bedside table, at eye level, 60 cm from the patient. Patients will receive phototherapy in 60 minute sessions, 3 times daily for 5 days.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Feasibility of 5-day phototherapy protocol
Feasibility will be defined as the percentage of eligible patients who choose to enroll in the study out of total patients approached.
Time frame: Day 5
Acceptability of 5-day phototherapy protocol
Accessibility will be defined as the percentage of study participants to complete at least one session per day of the 5-day protocol
Time frame: Day 5
Tolerability of 5-day phototherapy protocol
Tolerability will be defined as percentage of patients to rate phototherapy as 'very tolerable' based on being asked "Considering all aspects of your experience, how would you rate the overall tolerability of the phototherapy?" The response options are: very tolerable, somewhat tolerable, neutral, somewhat intolerable, and very intolerable.
Time frame: Day 5
Sleep duration
Sleep duration will be reported by nursing staff in hours.
Time frame: Day 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.